高钾血症
基线(sea)
锆
内科学
医学
心脏病学
材料科学
冶金
地质学
海洋学
作者
Mikhail Kosiborod,David Cherney,Kim A. Connelly,Akshay S. Desai,Patrícia O. Guimarães,L Kuthi,Anuradha Lala,Vagner Madrini,Béla Merkely,Julio Núñez,Iain Squire,Jeffrey M. Testani,J. Václavík,Subodh Verma,Jerzy Krzysztof Wranicz,Magnus Dahl,James M. Eudicone,Lovisa Friberg,Mark C. Petrie
标识
DOI:10.1016/j.jchf.2024.05.003
摘要
Mineralocorticoid receptor antagonists (MRAs) improve outcomes in patients with heart failure and reduced ejection fraction (HFrEF). However, MRAs are often underused because of hyperkalemia concerns.
科研通智能强力驱动
Strongly Powered by AbleSci AI